Use of nebulizer in berodual treatment of patients with chronic obstructive bronchitis in exacerbation

AIM: To study efficiency and safety of berodual in solution for inhalations delivered with the help of nebulizer in patients with exacerbation of chronic bronchitis (CB). MATERIALS AND METHODS: 12 patients with chronic bronchitis who had not responded to oral methylxantines in combination with expectorants received berodual for 10 days (1 ml 3 times a day). RESULTS: In the course of berodual treatment all the CB symptoms relieved and external respiration function improved. CONCLUSION: Berodual is effective as monotherapy of chronic obstructive bronchitis.